Neurorestoration therapeutics for neurodegenerative and psychiatric disease

Neurological Research
Martin M Bednar, Ann Perry

Abstract

Neurorestoration within the human central nervous system (CNS) is a concept that is barely a decade old. Despite this, there is significant clinical activity in this area, although there has not been any attempt to systematically identify these trials and organize them by disease area and phase of development. The objective of this investigation is to broadly review the current state of neurorestorative clinical trial activity ongoing worldwide. Iterative searches of the databases clinicaltrials.gov, EU Clinical Trials Register and ADIS Insight were used to locate clinical trials identified as involving neurorecovery/restoration strategies or stem cells for central nervous system diseases. A wide range of neurorestorative clinical trials (N = 106) are ongoing or planned. Nearly three-fourths of all clinical trials (75/106) are targeting one of four disease areas: multiple sclerosis, stroke, Parkinson's disease, and amyotrophic lateral sclerosis. Nearly two-thirds (63%) of 106 ongoing and planned clinical trials focus on cell-based therapy, although these are almost exclusively in phase 1 or 2 of development. Neurorecovery is an emerging field that is currently focused on earlier stages of clinical development, primarily in four...Continue Reading

References

Nov 11, 1998·Nature Medicine·P S ErikssonF H Gage
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L BrinesA Cerami
Sep 25, 2002·Neurobiology of Disease·Luc DupuisJean-Philippe Loeffler
Nov 2, 2002·Stroke; a Journal of Cerebral Circulation·Ruilan ZhangMichael Chopp
Jun 5, 2003·Annals of Neurology·Jieli ChenMichael Chopp
Oct 31, 2003·Neurochemical Research·Jeffrey A KleimTimothy Schallert
May 10, 2005·European Journal of Endocrinology·Marta BondanelliEttore C degli Uberti
Jun 2, 2005·Nature Reviews. Neuroscience·Michael Brines, Anthony Cerami
Oct 3, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Randolph J Nudo
Aug 21, 2007·Current Pharmaceutical Design·A R Walmsley, A K Mir
Nov 1, 2007·Expert Opinion on Investigational Drugs·Andrea C WilsonCraig S Atwood
Dec 1, 2007·Stroke; a Journal of Cerebral Circulation·Geoffrey A Donnan
Feb 22, 2008·CNS & Neurological Disorders Drug Targets·Stephen D Skaper
Jul 10, 2008·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Arthur A Vandenbark, Rivka Abulafia-Lapid
Aug 2, 2008·Expert Review of Neurotherapeutics·David C Hess, Cesar V Borlongan
Feb 3, 2009·Neurobiology of Aging·Elke BogaertLudo Van Den Bosch
Mar 21, 2009·Journal of Neuroscience Research·Seung U Kim, Jean de Vellis
Mar 26, 2009·Acta Neuropathologica·Robert D Bell, Berislav V Zlokovic
Apr 14, 2009·Cell Adhesion & Migration·Deepti NavaratnaEng H Lo
Sep 8, 2009·Advances in Experimental Medicine and Biology·Oliver von Bohlen und Halbach, Klaus Unsicker
Jan 20, 2010·Lancet Neurology·Clifford R JackJohn Q Trojanowski
Jan 22, 2010·Current Medicinal Chemistry·Corinna TrebstMartin Stangel
Feb 10, 2010·Experimental & Translational Stroke Medicine·Wolf-Rüdiger Schäbitz, Christoph Kleinschnitz
May 22, 2010·Current Opinion in Neurology·Laura E AllanPatrik Brundin
Jun 18, 2010·Journal of Alzheimer's Disease : JAD·Tim D BoydHuntington Potter
Jun 25, 2010·Annual Review of Neuroscience·Wolfgang KelschCarlos Lois
Oct 16, 2010·Critical Care Research and Practice·R NirulaK Waxman
Nov 1, 2008·Therapeutic Advances in Neurological Disorders·Claudia BartelsHannelore Ehrenreich
Jan 29, 2011·Stroke; a Journal of Cerebral Circulation·Sean I SavitzUNKNOWN STEPS Participants
Feb 16, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Raymond T BartusJeffrey H Kordower
Apr 12, 2011·Current Neurology and Neuroscience Reports·Jennifer Witt, William J Marks
May 11, 2011·Archives of Neurology·Louis R CaplanElizabeth Tournier-Lasserve
Jun 28, 2011·BMC Neurology·Ana M EnciuBogdan O Popescu
Jul 19, 2011·Neurology Research International·Stephana CarelliAlfredo Gorio
Oct 1, 2011·Nature Reviews. Drug Discovery·Darryle D Schoepp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Central Nervous System Agents in Medicinal Chemistry
DeRen Huang, Alexander Rae-Grant
Current Opinion in Investigational Drugs
Martin M Bednar
Stroke; a Journal of Cerebral Circulation
Antoni Dávalos, Julio Secades
© 2022 Meta ULC. All rights reserved